Insufficient scRNA-seq data for expression of TRIM21 at single-cell level.
Insufficient scRNA-seq data for expression of TRIM21 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 1301.08 | 965 / 966 | 100% | 52.63 | 527 / 527 |
esophagus | 100% | 1061.15 | 1443 / 1445 | 100% | 34.71 | 183 / 183 |
thymus | 100% | 889.48 | 653 / 653 | 100% | 41.17 | 603 / 605 |
kidney | 100% | 929.70 | 89 / 89 | 100% | 44.43 | 898 / 901 |
lung | 100% | 1384.55 | 578 / 578 | 100% | 42.81 | 1151 / 1155 |
prostate | 100% | 947.71 | 245 / 245 | 100% | 35.30 | 500 / 502 |
ovary | 100% | 1177.08 | 180 / 180 | 100% | 35.58 | 428 / 430 |
breast | 100% | 970.63 | 459 / 459 | 99% | 44.28 | 1110 / 1118 |
bladder | 100% | 960.14 | 21 / 21 | 99% | 44.68 | 500 / 504 |
stomach | 99% | 955.90 | 357 / 359 | 100% | 46.28 | 285 / 286 |
uterus | 100% | 1124.76 | 170 / 170 | 99% | 46.58 | 453 / 459 |
skin | 100% | 834.13 | 1808 / 1809 | 98% | 47.07 | 464 / 472 |
liver | 100% | 659.05 | 225 / 226 | 98% | 27.07 | 396 / 406 |
pancreas | 95% | 469.77 | 313 / 328 | 98% | 42.61 | 175 / 178 |
adrenal gland | 100% | 977.42 | 258 / 258 | 91% | 21.59 | 210 / 230 |
brain | 70% | 235.49 | 1859 / 2642 | 94% | 25.16 | 665 / 705 |
adipose | 100% | 1060.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 30.21 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 79.35 | 29 / 29 |
spleen | 100% | 2472.96 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 52.12 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.11 | 1 / 1 |
peripheral blood | 100% | 3418.70 | 928 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 937.39 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 489.67 | 853 / 861 | 0% | 0 | 0 / 0 |
muscle | 71% | 208.59 | 573 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0090086 | Biological process | negative regulation of protein deubiquitination |
GO_0016567 | Biological process | protein ubiquitination |
GO_0062197 | Biological process | cellular response to chemical stress |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0051091 | Biological process | positive regulation of DNA-binding transcription factor activity |
GO_0045087 | Biological process | innate immune response |
GO_0010498 | Biological process | proteasomal protein catabolic process |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0032880 | Biological process | regulation of protein localization |
GO_0051865 | Biological process | protein autoubiquitination |
GO_0070269 | Biological process | pyroptotic inflammatory response |
GO_0046598 | Biological process | positive regulation of viral entry into host cell |
GO_0031648 | Biological process | protein destabilization |
GO_0032479 | Biological process | regulation of type I interferon production |
GO_0034341 | Biological process | response to type II interferon |
GO_0032088 | Biological process | negative regulation of NF-kappaB transcription factor activity |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0045824 | Biological process | negative regulation of innate immune response |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0035617 | Biological process | stress granule disassembly |
GO_0044314 | Biological process | protein K27-linked ubiquitination |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0044790 | Biological process | suppression of viral release by host |
GO_0006513 | Biological process | protein monoubiquitination |
GO_0046596 | Biological process | regulation of viral entry into host cell |
GO_0032897 | Biological process | negative regulation of viral transcription |
GO_0045787 | Biological process | positive regulation of cell cycle |
GO_0085020 | Biological process | protein K6-linked ubiquitination |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000932 | Cellular component | P-body |
GO_0005829 | Cellular component | cytosol |
GO_0005776 | Cellular component | autophagosome |
GO_0005737 | Cellular component | cytoplasm |
GO_0019005 | Cellular component | SCF ubiquitin ligase complex |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0004842 | Molecular function | ubiquitin-protein transferase activity |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | TRIM21 |
Protein name | Tripartite motif containing 21 E3 ubiquitin-protein ligase TRIM21 (EC 2.3.2.27) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21) |
Synonyms | SSA1 RNF81 RO52 |
Description | FUNCTION: E3 ubiquitin-protein ligase whose activity is dependent on E2 enzymes, UBE2D1, UBE2D2, UBE2E1 and UBE2E2 . Forms a ubiquitin ligase complex in cooperation with the E2 UBE2D2 that is used not only for the ubiquitination of USP4 and IKBKB but also for its self-ubiquitination . Component of cullin-RING-based SCF (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complexes such as SCF(SKP2)-like complexes . A TRIM21-containing SCF(SKP2)-like complex is shown to mediate ubiquitination of CDKN1B ('Thr-187' phosphorylated-form), thereby promoting its degradation by the proteasome . Monoubiquitinates IKBKB that will negatively regulates Tax-induced NF-kappa-B signaling . Negatively regulates IFN-beta production post-pathogen recognition by catalyzing polyubiquitin-mediated degradation of IRF3 . Mediates the ubiquitin-mediated proteasomal degradation of IgG1 heavy chain, which is linked to the VCP-mediated ER-associated degradation (ERAD) pathway . Promotes IRF8 ubiquitination, which enhanced the ability of IRF8 to stimulate cytokine genes transcription in macrophages (By similarity). Plays a role in the regulation of the cell cycle progression . Enhances the decapping activity of DCP2 . Exists as a ribonucleoprotein particle present in all mammalian cells studied and composed of a single polypeptide and one of four small RNA molecules . At least two isoforms are present in nucleated and red blood cells, and tissue specific differences in RO/SSA proteins have been identified . The common feature of these proteins is their ability to bind HY RNAs.2 . Involved in the regulation of innate immunity and the inflammatory response in response to IFNG/IFN-gamma . Organizes autophagic machinery by serving as a platform for the assembly of ULK1, Beclin 1/BECN1 and ATG8 family members and recognizes specific autophagy targets, thus coordinating target recognition with assembly of the autophagic apparatus and initiation of autophagy . Regulates also autophagy through FIP200/RB1CC1 ubiquitination and subsequent decreased protein stability . Represses the innate antiviral response by facilitating the formation of the NMI-IFI35 complex through 'Lys-63'-linked ubiquitination of NMI . During viral infection, promotes cell pyroptosis by mediating 'Lys-6'-linked ubiquitination of ISG12a/IFI27, facilitating its translocation into the mitochondria and subsequent CASP3 activation . When up-regulated through the IFN/JAK/STAT signaling pathway, promotes 'Lys-27'-linked ubiquitination of MAVS, leading to the recruitment of TBK1 and up-regulation of innate immunity . Mediates 'Lys-63'-linked polyubiquitination of G3BP1 in response to heat shock, leading to stress granule disassembly . . |
Accessions | H0YDP8 ENST00000533692.1 ENST00000254436.8 [P19474-1] P19474 |